TW200634022A - Difluoronucleosides and process for preparation thereof - Google Patents

Difluoronucleosides and process for preparation thereof

Info

Publication number
TW200634022A
TW200634022A TW094143372A TW94143372A TW200634022A TW 200634022 A TW200634022 A TW 200634022A TW 094143372 A TW094143372 A TW 094143372A TW 94143372 A TW94143372 A TW 94143372A TW 200634022 A TW200634022 A TW 200634022A
Authority
TW
Taiwan
Prior art keywords
protected
base
preparation
group
difluorofuranose
Prior art date
Application number
TW094143372A
Other languages
English (en)
Chinese (zh)
Inventor
Anne-Ruth Born
Pierre Martin
Dirk Spielvogel
Marco Villa
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of TW200634022A publication Critical patent/TW200634022A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094143372A 2004-12-08 2005-12-08 Difluoronucleosides and process for preparation thereof TW200634022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63437604P 2004-12-08 2004-12-08

Publications (1)

Publication Number Publication Date
TW200634022A true TW200634022A (en) 2006-10-01

Family

ID=36147231

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094143372A TW200634022A (en) 2004-12-08 2005-12-08 Difluoronucleosides and process for preparation thereof

Country Status (10)

Country Link
US (1) US20060173174A1 (https=)
EP (1) EP1819718A1 (https=)
JP (1) JP2007522151A (https=)
KR (1) KR20070073958A (https=)
CN (1) CN101076535A (https=)
CA (1) CA2586687A1 (https=)
IL (1) IL183702A0 (https=)
MX (1) MX2007006837A (https=)
TW (1) TW200634022A (https=)
WO (1) WO2006063105A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
JP5687687B2 (ja) 2009-04-06 2015-03-18 大塚製薬株式会社 癌を治療するための(2’−デオキシ−リボフラノシル)−1,3,4,7−テトラヒドロ−(1,3)ジアゼピン−2−オン誘導体
UY32546A (es) 2009-04-06 2010-10-29 Eisai Inc Composiciones y metodos para tratar cancer
AU2010234562B2 (en) 2009-04-06 2016-05-12 Taiho Pharmaceutical Co., Ltd. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
CN105693795A (zh) * 2014-08-13 2016-06-22 陈欣 能破坏细胞复制的二氟代核苷类抗癌药的制备方法
WO2025235664A1 (en) * 2024-05-07 2025-11-13 Emory University Purine nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541566A (de) * 1969-04-11 1973-09-15 Schering Ag Verfahren zur Herstellung von Nucleosiden
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
JPH0673086A (ja) * 1992-06-22 1994-03-15 Eli Lilly & Co 立体選択的な陰イオングリコシル化法
US5594124A (en) * 1992-06-22 1997-01-14 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US7265096B2 (en) * 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN1228342C (zh) * 2003-04-08 2005-11-23 深圳市汉德森技术有限公司 以1,6-脱水-β-D-葡萄糖为原料制备2'-脱氧-2',2'-二氟-β-核胞苷或其药用盐的方法

Also Published As

Publication number Publication date
IL183702A0 (en) 2007-09-20
CN101076535A (zh) 2007-11-21
US20060173174A1 (en) 2006-08-03
JP2007522151A (ja) 2007-08-09
WO2006063105A1 (en) 2006-06-15
KR20070073958A (ko) 2007-07-10
CA2586687A1 (en) 2006-06-15
EP1819718A1 (en) 2007-08-22
MX2007006837A (es) 2007-10-23

Similar Documents

Publication Publication Date Title
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
TW200635930A (en) Bicyclic pyrrole derivatives
MY144322A (en) 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
WO2006044958A8 (en) Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
IL144668A0 (en) The use of 4-h-1-benzopyran-4- one derivatives as inhibitors of smooth muscle cell proliferation
TW200607806A (en) Pyrimidines as plk inhibitors
DE50302975D1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
PL3109244T3 (pl) Wytwarzanie 2'fluoro-2'-alkilo-podstawionych lub innych ewentualnie podstawionych rybofuranozylopirymidyn i puryn oraz ich pochodnych
UA84275C2 (ru) 8-[3-аминопиперидин-1-ил]ксантины, способ их получения и их применение как лекарственных средств
MXPA05011522A (es) Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica.
MY132106A (en) New pyridazin-3(2h)-one derivatives
IL145364A0 (en) Aminopyrimidines as sorbitol dehydrogenase inhibitors
MA29799B1 (fr) Administration d'inhibiteurs de dipeptidyl peptidase
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
ATE393769T1 (de) Stickstoff substituierte hexahydro-pyrazino 1,2-a pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TW200612958A (en) Substituted imidazole derivatives
MXPA04000886A (es) Derivados de triazolil-imidazopiridina y triazolilpurinas empledos como ligandos del receptor de adenosina a2a y su uso como medicamentos.
AU2003238026A1 (en) Shaped articles with improved stability
GB0308201D0 (en) Novel compounds
ZA200703005B (en) Preparation of 2'Fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
WO2006000371A3 (en) Pyrimidine derivatives as 11beta-hsd1 inhibitors
GEP20094697B (en) Condensed purine derivatives as a1 adenosine receptor antagonists
TW200634022A (en) Difluoronucleosides and process for preparation thereof
AU4579500A (en) Small electronic articles for personal use
WO2003068776A1 (en) [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES